Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Aocheng Biotechnology is a high-tech enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) products. Based in Wuhan's Optics Valley, the company focuses on point-of-care testing (POCT), molecular diagnostics, and chemiluminescence technologies. Their product portfolio includes automated analyzers and a wide range of diagnostic kits for infectious diseases, cardiac markers, and inflammatory indicators. Aocheng provides integrated solutions for clinical laboratories and primary healthcare settings, emphasizing rapid and accurate diagnostic results. The company has gained significant recognition for its rapid response during public health emergencies, particularly with its molecular diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Aocheng Biotechnology.